PBM
Propel Bio Management Portfolio holdings
AUM
$82.4M
This Quarter Return
-15.48%
1 Year Return
+29.32%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$101M
AUM Growth
+$101M
(-42%)
Cap. Flow
-$1.25M
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
90.34%
Holding
23
New
2
Increased
4
Reduced
2
Closed
2
Top Buys
| 1 |
Applied Therapeutics
APLT
|
$2.61M |
| 2 |
Phathom Pharmaceuticals
PHAT
|
$974K |
| 3 |
Syndax Pharmaceuticals
SNDX
|
$661K |
| 4 |
Jasper Therapeutics
JSPR
|
$428K |
| 5 |
Delcath Systems
DCTH
|
$205K |
Top Sells
| 1 |
Telesat
TSAT
|
$4.82M |
| 2 |
Ardelyx
ARDX
|
$608K |
| 3 |
Verrica Pharmaceuticals
VRCA
|
$500K |
| 4 |
CMPS
Compass Pathways
CMPS
|
$207K |
Sector Composition
| 1 | Healthcare | 76.74% |
| 2 | Energy | 23.23% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Plains GP Holdings
PAGP
$3.82B
| $23.4M | 23.23% | 1,272,360 | – | – |
|
2
Madrigal Pharmaceuticals
MDGL
$9.76B
| $13.3M | 13.19% | 43,032 | – | – |
|
3
Akero Therapeutics
AKRO
$3.74B
| $9.56M | 9.5% | 343,729 | – | – |
|
4
Achieve Life Sciences
ACHV
$152M
| $8.63M | 8.58% | 2,453,092 | – | – |
|
|
5
Applied Therapeutics
APLT
$71M
| $8.23M | 8.18% | 9,615,420 +3,047,562 | +46% | +$2.61M |
|
|
6
Phathom Pharmaceuticals
PHAT
$864M
| $8.04M | 7.98% | 989,927 +120,000 | +14% | +$974K |
|
7
TScan Therapeutics
TCRX
$102M
| $6.34M | 6.3% | 2,087,139 | – | – |
|
8
Avidity Biosciences
RNA
$5.99B
| $5.19M | 5.16% | 178,500 | – | – |
|
|
9
Ardelyx
ARDX
$1.53B
| $4.82M | 4.79% | 950,947 -120,000 | -11% | -$608K |
|
10
Abeona Therapeutics
ABEO
$350M
| $3.48M | 3.45% | 624,022 | – | – |
|
|
11
Syndax Pharmaceuticals
SNDX
$1.41B
| $2.42M | 2.41% | 183,259 +50,000 | +38% | +$661K |
|
12
Kymera Therapeutics
KYMR
$2.95B
| $2.27M | 2.25% | 56,359 | – | – |
|
13
Zevra Therapeutics
ZVRA
$509M
| $1.5M | 1.49% | 179,874 | – | – |
|
14
Kura Oncology
KURA
$686M
| $1.13M | 1.12% | 130,000 | – | – |
|
15
Athira Pharma
ATHA
$15.3M
| $876K | 0.87% | 1,492,792 | – | – |
|
|
EIGR
16
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $765K | 0.76% | 146,381 | – | – |
|
|
17
Jasper Therapeutics
JSPR
$45.5M
| $428K | 0.42% | +20,000 | New | +$428K |
|
|
18
Delcath Systems
DCTH
$385M
| $205K | 0.2% | +17,000 | New | +$205K |
|
|
CMPS
19
Compass Pathways
CMPS
$424M
| $95.3K | 0.09% | 25,209 -54,791 | -68% | -$207K |
|
|
20
Telesat
TSAT
$307M
| – | – | -365,781 | Closed | -$4.82M |
|
|
21
Verrica Pharmaceuticals
VRCA
$52.8M
| – | – | -344,937 | Closed | -$500K |
|